Lumida
/ICUI
⌘K
ICU Medical Inc

ICU Medical Inc

ICUI
$156.48USD-0.50%-0.78 today

MARKET CAP

3.9B

P/E (TTM)

84.1x

FWD P/E

DAY RANGE

$155 – $162

52W RANGE

$113
$193

AI Summary

Stalk
TrimMedium

Price has decisively broken key support and entered a structured downtrend, with EMAs rolling over and lower highs confirmed. Oversold conditions and extension below the EMA stack suggest caution against immediate selling. Medium-term bias is bearish, so execution should be deferred and focused on pullbacks into the broken support zone near prior resistance.

  • Adjusted EPS $2.37 (+13% YoY) beat estimates; FY26 EPS guidance raised to $8.60–$9.00.
  • Q2 revenue $548M (+1% YoY, +6% organic), adjusted EBITDA $110M (20% margin, +10% YoY).
  • Negative profitability factor indicates ongoing margin pressures and pricing headwinds.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.3B$2.3B$2.3B$2.4B$2.2B
YoY %+3.6%+73.2%-0.9%+5.4%-6.3%
P / Sales3.9x1.7x1.1x1.6x1.6x
EV / Sales3.7x2.6x2.0x2.4x2.3x
Gross Profit, Adj.$491.5M$697.8M$739.9M$824.8M$822.0M
YoY %+6.5%+42.0%+6.0%+11.5%-0.3%
Margin %37.3%30.6%32.8%34.6%36.8%
EV / Gross Profit9.9x8.6x6.0x6.9x6.3x
EBITDA, Adj.$241.2M$258.1M$292.9M$322.3M$310.1M
YoY %+5.1%+7.0%+13.5%+10.1%-3.8%
Margin %18.3%11.3%13.0%13.5%13.9%
EV / EBITDA20.2x23.4x15.2x17.7x16.7x
EBIT$141.3M$-42.9M$22.8M$43.0M$42.8M
YoY %+43.9%-130.4%+153.2%+88.2%-0.3%
Margin %10.7%-1.9%1.0%1.8%1.9%
EV / EBIT34.6x-140.6x194.9x133.0x120.8x
Net Income$103.1M$-74.3M$-29.7M$-117.7M$732,000
YoY %+18.7%-172.0%+60.1%-296.9%+100.6%
Net Margin7.8%-3.3%-1.3%-4.9%0.0%
EPS (GAAP)$4.74-$3.11-$1.23-$4.83$0.03
YoY %+17.9%-165.6%+60.5%-292.7%+100.6%